Ovarian damage from chemotherapy and current approaches to its protection

N Spears, F Lopes, A Stefansdottir… - Human reproduction …, 2019 - academic.oup.com
Background Anti-cancer therapy is often a cause of premature ovarian insufficiency and
infertility since the ovarian follicle reserve is extremely sensitive to the effects of …

Sex and gender influences on cancer immunotherapy response

A Irelli, MM Sirufo, C D'Ugo, L Ginaldi, M De Martinis - Biomedicines, 2020 - mdpi.com
The global burden of cancer is growing and a wide disparity in the incidence, malignancy
and mortality of different types of cancer between each sex has been demonstrated. The sex …

Decrease post-transplant relapse using donor-derived expanded NK-cells

SO Ciurea, P Kongtim, D Soebbing, P Trikha… - Leukemia, 2022 - nature.com
In this phase I/II clinical trial, we investigated the safety and efficacy of high doses of mb-IL21
ex vivo expanded donor-derived NK cells to decrease relapse in 25 patients with myeloid …

Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a …

N Gagelmann, A Bacigalupo, A Rambaldi… - JAMA …, 2019 - jamanetwork.com
Importance Use of haploidentical (HAPLO) stem cell transplantation with posttransplant
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …

Treatment of allosensitized patients receiving allogeneic transplantation

SO Ciurea, MM Al Malki, P Kongtim, J Zou… - Blood …, 2021 - ashpublications.org
Donor-specific anti-HLA antibodies (DSAs) are a major cause of engraftment failure in
patients receiving haploidentical stem cell transplantation (HaploSCT). Effective treatments …

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

SR McCurdy, L Luznik - Hematology 2014, the American …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …

Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies

R Iftikhar, F Anwer, K Neupane, A Rafae, SK Mahmood… - Blood reviews, 2021 - Elsevier
Abstract Treatment options for newly diagnosed aplastic anemia (AA) patient includes
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …

Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study

YJ Chang, Y Wang, LP Xu, XH Zhang, H Chen… - Journal of hematology & …, 2020 - Springer
Background Previous reports suggest a benefit associated with haploidentical donor
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …

Updated trends in hematopoietic cell transplantation in the United States with an additional focus on adolescent and young adult transplantation activity and outcomes

R Phelan, M Chen, C Bupp, YT Bolon, L Broglie… - … and cellular therapy, 2022 - Elsevier
Hematopoietic cell transplantation (HCT) has been successfully used to treat many
malignant and nonmalignant conditions. As supportive care, donor selection, and treatment …

NK cell-based immunotherapy for hematological malignancies

S Sivori, R Meazza, C Quintarelli… - Journal of Clinical …, 2019 - mdpi.com
Natural killer (NK) lymphocytes are an integral component of the innate immune system and
represent important effector cells in cancer immunotherapy, particularly in the control of …